BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6126106)

  • 21. Effect of beta adrenergic blocking agents on erythropoiesis in rats.
    Zivný J; Ostádal B; Neuwirt J; Procházka J; Pelouch V
    J Pharmacol Exp Ther; 1983 Jul; 226(1):222-5. PubMed ID: 6134822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effect of indenolol on systemic arterial pressure and heart rate in the rat.
    Zuccari G; Falcone A; Turba C
    Pharmacol Res Commun; 1986 Feb; 18(2):137-47. PubMed ID: 2871567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 24. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.
    Bilski A; Wale J; Dawes PM
    Br J Pharmacol; 1976 Mar; 56(3):362P. PubMed ID: 4182
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of beta adrenoceptor blocking drugs on the integrity of rat platelets as measured by 51Cr liberation.
    Turcáni P; Nosál R
    Thromb Res; 1981 Jul 1-15; 23(1-2):187-91. PubMed ID: 6117953
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
    Ceremuzynski L; Zaleska T; Nauman J; Nauman A; Zalewski A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):244-9. PubMed ID: 38215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between the potency of seven potential beta-adrenoceptor blocking drugs and propranolol to decrease heart rate in reserpinized rats and to perturb liposomes prepared from platelet lipids.
    Ondriasova E; Stasko A; Racanská E; Svec P; Ondrias K
    Pharmazie; 1991 Dec; 46(12):889-90. PubMed ID: 1687834
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.
    Zaagsma J; Meems L; Boorsma M
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):29-36. PubMed ID: 18685
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].
    Leonhardt U; Nürnberger H; Femmer K
    Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of propranolol, pindolol and carteolol on acute regional myocardial ischemia in isolated rabbit hearts.
    Rump AF; Picke D; Rösen R; Klaus W
    Arzneimittelforschung; 1993 Jun; 43(6):641-5. PubMed ID: 8102527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation.
    Da Re P; Valenti P; Fabbri G; Frigeni V; Reggiani A; Della Bella D
    Drugs Exp Clin Res; 1988; 14(11):687-92. PubMed ID: 2907738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
    Dubach UC
    Schweiz Rundsch Med Prax; 1975 Sep; 64(39):1239-41. PubMed ID: 241073
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of propranolol and trimepranol on the conditioned avoidance response.
    Tikal K; Plevová J
    Act Nerv Super (Praha); 1983 Dec; 25(4):309-11. PubMed ID: 6141694
    [No Abstract]   [Full Text] [Related]  

  • 35. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cholinergic antagonism by beta-blockers. I. Spectrum of interactions].
    Re L; Giorgetti F; Rossini L
    Boll Soc Ital Biol Sper; 1980 May; 56(9):892-8. PubMed ID: 6108773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
    Goch JH
    Pol Tyg Lek; 1972 Dec; 27(52):2049-51. PubMed ID: 4405621
    [No Abstract]   [Full Text] [Related]  

  • 38. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
    Mouillé P; Cheymol G
    C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
    [No Abstract]   [Full Text] [Related]  

  • 39. Heart rate after combined vagal and sympathetic blockade with atropine and different beta-receptor blocking agents.
    Fenyvesi T; Káldor A; Sebestyén K
    Int J Clin Pharmacol; 1973 Nov; 8(3):254-7. PubMed ID: 4149237
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
    Hugues FC; Le Jeunne C; Munera Y; Dufier JL
    J Fr Ophtalmol; 1987; 10(8-9):485-90. PubMed ID: 2892874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.